Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by M I Greene
YAP Modifies Cancer Cell Sensitivity to EGFR and Survivin Inhibitors and Is Negatively Regulated by the Non-Receptor Type Protein Tyrosine Phosphatase 14
Oncogene
Cancer Research
Genetics
Molecular Biology
Antigen- And Receptor-Driven Regulatory Mechanisms. II. Induction of Suppressor T Cells With Idiotype-Coupled Syngeneic Spleen Cells
Journal of Experimental Medicine
Medicine
Allergy
Immunology
Related publications
The Non-Receptor Tyrosine Phosphatase Type 14 Blocks Caveolin-1-Enhanced Cancer Cell Metastasis
Oncogene
Cancer Research
Genetics
Molecular Biology
Negative Regulation of T Cell Activation by Placental Protein 14 Is Mediated by the Tyrosine Phosphatase Receptor CD45
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
An Integrated Computational Approach for Plant-Based Protein Tyrosine Phosphatase Non-Receptor Type 1 Inhibitors
Current Computer-Aided Drug Design
Medicine
Drug Discovery
Molecular Medicine
Molecular Imaging for Detection of Sensitivity and Resistance to EGFR Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer
Clinical and Translational Imaging
Nuclear Medicine
Radiology
Imaging
Protein-Tyrosine Phosphatase H1 Increases Breast Cancer Sensitivity to Antiestrogens by Dephosphorylating Estrogen Receptor at Tyr537
Molecular Cancer Therapeutics
Cancer Research
Oncology
PTPRR (Protein Tyrosine Phosphatase, Receptor Type, R)
Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer Research
Oncology
Genetics
Hematology
Synapse Formation Regulated by Protein Tyrosine Phosphatase Receptor T Through Interaction With Cell Adhesion Molecules and Fyn
EMBO Journal
Immunology
Molecular Biology
Biochemistry
Microbiology
Neuroscience
Medicine
Genetics
Influence of EGFR-activating Mutations on Sensitivity to Tyrosine Kinase Inhibitors in a KRAS Mutant Non-Small Cell Lung Cancer Cell Line
PLoS ONE
Multidisciplinary
Intrinsic Resistance to EGFR Tyrosine Kinase Inhibitors in Advanced Non-Small-Cell Lung Cancer With Activating EGFR Mutations
OncoTargets and Therapy
Oncology
Pharmacology
